XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses    
Research and development $ 6,635 $ 5,653
General and administrative 3,224 3,352
Total operating expenses 9,859 9,005
Loss from operations (9,859) (9,005)
Other income/(expense), net (5) 5
Loss before income tax benefit (9,864) (9,000)
Income tax benefit   501
Net loss and comprehensive loss $ (9,864) $ (8,499)
Net loss per share, basic and diluted $ (0.69) $ (0.57)
Weighted-average common shares outstanding, basic and diluted 14,330,693 14,831,049